BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 21, 2008
View Archived Issues
Biotech's 1st Quarter '08 Fails to Fire Up Market
Read More
Influenza Travel Patterns May Enable Longer-Term Forecasts
Read More
AACR Roundup
Read More
Financings Roundup
Read More
Clinic Roundup
Read More
AAN Roundup
Read More
Other News To Note
Read More
Elan-Wyeth Alzheimer's Trial Suspended Due to Skin Lesion
A Phase II trial of the ACC-011 compound for Alzheimer's disease being developed by Elan Corp. plc and Wyeth Pharmaceuticals has been suspended due to a skin lesion observed in a single patient. (BioWorld Today)
Read More
Biotechs Plead Their Case in the Halls of Congress
Read More
Stock Winners and Losers For The Week
Read More
Money Raised By Month
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More